LYPHOMED LMED TO MARKET ANTIBIOTIC ROSEMONT ILL March LyphoMed Inc said the Food and Drug Administration gave it approval to market Vancomycin HCL an antibiotic used in hospitals to treat life threatening infections It said the product is currently marketed by Eli Lilly and Co LLY under the trade name Vancocin Sales in were mln dlrs LyphoMed said its objective is to get a to pct share of the market Reuter